MGX · Metagenomi Therapeutics, Inc. · Proposed Sales
Market Cap
$31.40M
Shares
37.78M
Volume · Oct 21
47.1K
Avg daily vol (3M)
156.43K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.